✉news HealthMedicine first seen 6 d ago, last 6 d ago, peak #19
Optogenetic Therapy Shows Early Promise Against Retinitis Pigmentosa Blindness
Original: Optogenetic Therapy Shows Early Promise for Retinitis Pigmentosa-Associated Blindness
An optogenetic therapy is showing early promise in treating blindness caused by retinitis pigmentosa, according to reports in the medical press. The approach uses light-sensitive proteins introduced into retinal cells to restore some visual function in patients with the inherited degenerative eye disease. Early results suggest the experimental technique could offer hope where no effective treatment currently exists, though researchers caution the findings remain preliminary.
Why now: Early clinical findings suggest a possible treatment for an incurable inherited cause of blindness, drawing attention from patients and the medical community.
retinitis pigmentosaoptogenetic therapy
Evidence
- Optogenetic Therapy Shows Early Promise for Retinitis Pigmentosa-Associated Blindness · Inside Precision Medicine
API: https://socialmediatrends-api.osmike.com/v1/trends/1430521